PT Bundamedik Tbk (BMHS.JK)

Indonesia · Healthcare · IDR

Key financials

ROE: 0.68%; 2025 (actual)
ROA: 0.33%; 2025 (actual)
Gross Margin: 46.12%; 2025 (actual)
Net Margin: 0.77%; 2025 (actual)
Total Assets: IDR 4,016,429.44M; 2025 (actual)
Net Income: IDR 12,418.96M; 2025 (actual)
Valuation: -
Stock Price: IDR 188.9; 2026 (forecast)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026 (forecast)	2027	2028	2029	2030	2031
Gross Margin	46.12%	46.43%	46.43%	46.43%	46.43%	46.43%	46.43%
Sector average	-	35.01%	35.01%	35.01%	35.01%	35.01%	26.96%
Total Assets	IDR 4,016,429.44M	IDR 4,127,237.04M	IDR 4,135,205.62M	IDR 4,227,690.7M	IDR 4,375,607.51M	IDR 4,674,601.72M	IDR 4,835,331M
Sector average	-	IDR 7,871,198.25M	IDR 8,776,938.94M	IDR 9,968,979.01M	IDR 11,181,139.92M	IDR 12,214,160M

Amounts in IDR (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.

Want the full financial forecast report for PT Bundamedik Tbk? It covers the balance sheet, income statement and Equlion model projections.

Stock Price	-	IDR 188.9	IDR 188.9	IDR 188.9	IDR 188.9	IDR 188.9	IDR 188.9
Sector average	-	IDR 1,839.21	IDR 1,924.82	IDR 1,903.8	IDR 1,818.04	IDR 1,784.88	IDR 803.55